Skip to main content
Signal8

Patrick Kristin

SEC insider (Form 3/4/5 filer). CIK 0001769529. Director at Laird Superfood, Inc. (LSF) and 2 other issuers. 7 reported Form 4/5 transactions since Sep 2024; latest on Jul 9, 2026. Located in BOULDER, CO.

Companies Patrick Kristin has filed insider reports for

  • Laird Superfood, Inc. (LSF): Director
  • Niagen Bioscience, Inc. (NAGE): Director
  • Super League Enterprise, Inc. (SLE): Director
Patrick Kristin profile photo

Patrick Kristin

CIK: 0001769529

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)7 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

Laird Superfood, Inc. logo
LSF

Laird Superfood, Inc.

Director
Niagen Bioscience, Inc. logo
NAGE

Niagen Bioscience, Inc.

Director
Super League Enterprise, Inc. logo
SLE

Super League Enterprise, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Laird Superfood, Inc. logo
    LSF

    Laird Superfood, Inc.

    Jul 9, 2026
    Award

    Option (right to buy)

    Direct
    60K shares-
  • Laird Superfood, Inc. logo
    LSF

    Laird Superfood, Inc.

    Jul 9, 2026
    Award

    Option (right to buy)

    Direct
    25K shares-
  • Laird Superfood, Inc. logo
    LSF

    Laird Superfood, Inc.

    Jul 9, 2026
    Award

    Option (right to buy)

    Direct
    25K shares-
  • Niagen Bioscience, Inc. logo
    NAGE

    Niagen Bioscience, Inc.

    Jun 24, 2026
    Award

    Stock Option (right to buy)

    Direct
    31.7K shares-
  • Super League Enterprise, Inc. logo
    SLE

    Super League Enterprise, Inc.

    Oct 20, 2025
    Award
    Direct
    1.4K shares-
  • Super League Enterprise, Inc. logo
    SLE

    Super League Enterprise, Inc.

    Oct 1, 2025
    Award
    Direct
    962 shares-
  • Niagen Bioscience, Inc. logo
    NAGE

    Niagen Bioscience, Inc.

    Jun 24, 2025
    Award

    Stock Option (right to buy)

    Direct
    20K shares-

1-7 of 7